Early Versus Late Adjunctive Vasopressin in Septic Shock

Recruiting now · Phase 4

Conditions studied: Sepsis, Septic Shock

In brief

The goal of the CASPER-Pilot study is to develop clinical decision support (CDS) technology within Epic to randomize patients with septic shock to early versus standard of care vasopressin initiation. The primary aim of this study will be to test the hypothesis that CDS technology can be utilized to create two distinct cohorts of patients reflecting different times of vasopressin initiation based on norepinephrine dose requirements. Secondarily, this study will evaluate the proportion of patients whose norepinephrine dose at the time of vasopressin initiation is within the specified range for the intervention arm they were randomized to. Other outcomes of evaluation will include adherence to the developed CDS technology and comparison of clinical outcomes between the two treatment arms.

Key facts

Study ID

NCT06709573

Run by

The Cleveland Clinic

People needed

300

Starts

2025-04-29

Expected to finish

2026-05-01

Last updated by the study team

2026-03-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age ≥ 18 Years
• Diagnosis of Septic Shock
• Admitted to Cleveland Clinic Main Campus Medical ICU
• Receiving continuous infusion of norepinephrine at a dose > 5 mcg/min at time of enrollment

You may not qualify if…

• Administration of any other vasoactive agent other than norepinephrine at time of enrollment
• Initiation of vasopressin by provider outside of the context of study when NE < 10 mcg/min (before BPA firing)

Where it is running

• Cleveland Clinic — Cleveland, Ohio, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.